India, Aug. 19 -- Mumbai-based HiMedia Laboratories, a global leader in diagnostics and life sciences, has received manufacturing licenses from the Central Drugs Standard Control Organization (CDSCO) for two advanced molecular diagnostic kits:

These regulatory approvals empower HiGenoMB - HiMedia to manufacture these highly sensitive and specific diagnostic tools on a large scale, developed indigenously as part of the Make in India initiative to tackle two of the most significant viral infections impacting both the global and Indian populations. This achievement aligns strongly with HiGenoMB's vision to help make India hepatitis free by enabling early, accurate diagnosis and effective management of hepatitis B and C.

Hepatitis B and C a...